Longitudinal changes in CSF alpha‐synuclein species reflect Parkinson's disease progression
Movement Disorders2016Vol. 31(10), pp. 1535–1542
Citations Over TimeTop 10% of 2016 papers
Nour K. Majbour, Nishant N. Vaikath, Paolo Eusebi, Davide Chiasserini, Mustafa T. Ardah, Shiji Varghese, M. Emdadul Haque, Takahiko Tokuda, Peggy Auinger, Paolo Calabresi, Lucilla Parnetti, Omar M. A. El‐Agnaf
Abstract
Our data show that CSF α-synuclein species have a dynamic pattern along the course of the disease, supporting their possible role as progression biomarkers for PD and their link with PD clinical phenotypes. © 2016 International Parkinson and Movement Disorder Society.
Related Papers
- → Association of Misfolded α-Synuclein Derived from Neuronal Exosomes in Blood with Parkinson’s Disease Diagnosis and Duration(2024)28 cited
- → The potential of zwitterionic nanoliposomes against neurotoxic alpha-synuclein aggregates in Parkinson's Disease(2018)43 cited
- → Diagnostic accuracy and predictors of alpha-synuclein accumulation in the gastrointestinal tract of Parkinson’s disease(2024)7 cited
- → O.026 Mice over-expressing wild-type human alpha-synuclein as tools for therapeutic discovery in Parkinson's disease(2009)
- More than a synuclein story: Dissecting determinants for alpha-synuclein aggregation and degradation in the Parkinson’s disease brain(2020)